Transforming precision oncology - 4baseCare

Developed a first of its kind unique digital platform, OncoBuddy, which provides 360-degree holistic support to cancer patients

Inception-2018

Location- Bengaluru

Domain- Precision oncology

Founder- Hitesh Goswami (Chief Executive Officer) and Kshitij D Rishi (Chief Operating Officer)

Total team strength- 60 plus

Total funds raised- Rs 14.8 crore

Investors- Mount Judi Ventures, growX Ventures, Season Two Ventures, First In Ventures

Revenue generated since inception- NA

Key Highlights-

• First company from Asia-pacific to be selected for Illumina Accelerator
• Selection for AISEA Accelerator
• Selection for GE Edison Accelerator
• Launched a series of cancer gene panel tests
• Partnered with Wipro
• Launched the world's population-specific gene panel - TARGT Indiegene
• Developed a first of its kind unique digital platform, OncoBuddy, which provides 360-degree holistic support to cancer patients
• Over the next five years, plan to expand genomic test portfolio and increase presence in Southeast Asia

Founder Speaks-

"The current scenario is great for genomics startups in India. Having realized the potential and power of genomics in managing covid, the government, both at the centre and state level are supporting startups with innovative ideas. There is a lot of excitement and interest from investors, and more importantly, technology giants are looking to tap the startup potential in India. The GE Edison Programme will allow us to leverage GE healthcare’s deep expertise to build and integrate unique precision oncology solutions using GE’s advanced Edison Artificial Intelligence and Analytics platform."

- Kshitij D. Rishi, COO and Co-Founder, 4baseCare, Bengaluru

Published on : 25th May, 2022